Survival outcomes of the NeoALTTO study (BIG 1–06): updated results of a randomised multicenter phase III neoadjuvant clinical trial in patients with HER2-positive primary breast cancer
Jens Huober, Eileen Holmes, José Baselga, Evandro de Azambuja, Michael Untch, Debora Fumagalli, Severine Sarp, Istvan Lang, Ian Smith, Frances Boyle, Binghe Xu, Christophe Lecocq, Hans Wildiers, Christelle Jouannaud, John Hackman, Lokanatha Dasappa, Eva Ciruelos, Juan Carlos Toral Pena, Hryhoriy Adamchuk, Tamas Hickish, Lorena de la Pena, Christian Jackisch, Richard D. Gelber, Martine Piccart-Gebhart, Serena Di Cosimo
Manuscrito
EUROPEAN JOURNAL OF CANCER
2019
NeoALTTO
